[Effect of eprosartan on left ventricular diastolic function and cerebral hemodynamics in patients with hypertension]

Area of Science:

• Cardiology
• Neurology
• Pharmacology

Background:

• Hypertension (WHO stage II-III) can impair cardiac and cerebral hemodynamics.
• Left ventricular diastolic dysfunction is a common complication of hypertension.
• Cerebral blood flow regulation is often compromised in hypertensive individuals.

Purpose of the Study:

• To evaluate the effects of eprosartan on left ventricular diastolic function and cerebral blood flow in patients with moderate to severe hypertension.
• To assess the impact of eprosartan on cardiac structure and function, as well as cerebral vascular dynamics.

Main Methods:

• A 4-week open-label study involving 28 patients (32-62 years) with stage II-III hypertension.
• Eprosartan administered at doses of 600-1200 mg/day.
• Assessment of left ventricular diastolic function using echocardiography.
• Evaluation of cerebral blood flow and autoregulation via ultrasound dopplerography.

Main Results:

• Eprosartan treatment led to significant improvements in impaired left ventricular diastolic function.
• Observed enhancements in the structural and functional state of the heart.
• Improved venous outflow from cerebral vessels and restoration of cerebral blood flow autoregulation were noted.
• These cardiovascular and cerebrovascular effects suggest a potential for normalizing cerebral tissue perfusion.

Conclusions:

• Eprosartan demonstrates beneficial effects on both cardiac and cerebral hemodynamics in hypertensive patients.
• The drug improves left ventricular diastolic function and cerebral blood flow regulation.
• These findings indicate eprosartan's potential role in managing hypertension-related cardiovascular and cerebrovascular complications.